BIO To Unveil Innovative Polls Comparing Views of Top-Level Biotech Executives, Public on Key Biotech Issues
WASHINGTON, D.C. (April 23, 2007) -- The Biotechnology Industry Organization (BIO) will launch its 2007 BIO International Convention in Boston on May 6 with a special media-only brunch that will include the announcement of results of a one-of-a-kind public opinion research project conducted by two premier U.S. polling firms.
The research project, consistent with the theme of this year’s BIO International Convention, “New Ideas. Bold Ventures. Global Benefits,” encompasses the results of two separate polls conducted jointly by Republican and Democratic strategists. The surveys will allow pollsters for the first time to measure insider insights from top-level executives at biotechnology companies against the public’s perception of the biotechnology industry and its potential to solve some of world’s most pressing challenges.
Respondents from both groups were asked to respond to questions on a wide range of biotechnology issues including, the potential for biotherapies to alleviate and even cure devastating diseases such as Parkinson’s, HIV/AIDS and multiple sclerosis, the environmental and ethical implications of biofoods, and the promise of biofuels including ethanol to alleviate dependence on fossil fuels.
The formal presentation of survey results will be followed immediately by a panel of leading biotechnology company CEOs. These industry leaders, along with BIO President and CEO Jim Greenwood, will respond to the surveys’ findings.
BIO tapped two of the nation’s leading political polling firms –Public Opinion Strategies and Peter D. Hart Research Associates – to conduct the research. The results will be unveiled by Republican strategist Neil Newhouse, partner and co-founder of Public Opinion Strategies, and Democratic strategist Geoff Garin, president of Peter D. Hart Research Associates, at the Sunday morning media brunch.
A selection of biofoods will be served at the media brunch.
WHAT: BIO industry survey comparing biotech insiders’ view of the industry with the general public’s view
WHEN: May 6, 10:30 a.m. – 12:30 p.m.
WHERE: BIO International Convention in Boston, Level 3 Ballroom
WHO: Neil Newhouse, Public Opinion Strategies
Geoff Garin, Peter D. Hart Research Associates
Jim Greenwood, President and CEO of BIO
This year’s BIO International Convention will feature a program packed with more than 200 sessions and speakers focusing on the global aspects of biotechnology, including business development, global health, clinical research/clinical trials, policy, bioethics, devices and diagnostics, biopreparedness, intellectual property/legal, food and agriculture, and industrial and environmental issues. International seminars will spotlight national-level developments from more than 30 countries and regions worldwide. To view the full conference program, please visit www.bio2007.org/attendees/educational_sessions/index.html.
General registration for the BIO International Convention is now available at www.bio.org/registration/index.html. For more information about the global event for biotechnology, including housing and program updates, please visit the event homepage at www.bio2007.org.
Advance media registration for the BIO International Convention is now available online. Registration is complimentary for credentialed members of the news media. To register, please visit www.bio.org/media/index.html. Reporters and editors working full-time for print or broadcast news organizations may register onsite with valid media credentials. Freelancers, college and online publications are strongly encouraged to register in advance by Friday, April 20, 2007.
Founded in 1993, BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and 31 other nations. BIO members are involved in the research and development of health-care, agricultural, industrial and environmental biotechnology products. BIO produces the annual BIO International Convention, the world’s largest annual gathering of the biotechnology industry.
About Public Opinion Strategies
Public Opinion Strategies is a survey research company specializing in corporate, public policy and litigation research, with offices in Washington, Denver and Los Angeles. Since its founding in 1991, Public Opinion Strategies has completed more than 10,000 research projects and interviewed more than 4 million Americans across the United States. The projects have ranged in scope from neighborhood studies to national samples in all 50 states. Internationally, Public Opinion Strategies has completed research projects in Albania, Australia, Bulgaria, Canada, Guam, Israel, Kenya, Mexico, Mongolia, Montenegro, New Zealand, Poland, Russia, Serbia, Venezuela, South Africa, and the United Kingdom. Since Public Opinion Strategies' roots are in political campaign messaging, their research is focused on producing information that compels decisions - and then results.
About Peter D. Hart Research Associates
Peter D. Hart Research Associates is one of America’s leading public opinion research firms. For almost 40 years--through more than 5,000 surveys and 5,000 focus groups in all 50 states and across six continents--Hart Research has been at the forefront of identifying and understanding people's changing expectations, attitudes, and behaviors. Its clients include many of the country's leading foundations, corporations, trade associations, and public interest organizations, as well as Democratic elected officials at the federal, state, and local levels.